Cargando…
Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome
Noonan syndrome is a heterogeneous congenital disorder. The main features are typical facial features, short stature and cardiac defects. The diagnosis is clinical: in 80% of patients with Noonan syndrome a genetic defect can be shown. Inheritance is predominantly autosomal dominant and seldom autos...
Autores principales: | Dahlgren, Jovanna, Noordam, Cees |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999676/ https://www.ncbi.nlm.nih.gov/pubmed/35407641 http://dx.doi.org/10.3390/jcm11072034 |
Ejemplares similares
-
Cardiovascular safety of growth hormone treatment in Noonan syndrome: real-world evidence
por: Romano, Alicia, et al.
Publicado: (2021) -
GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome
por: Dahlgren, Jovanna, et al.
Publicado: (2021) -
Growth hormone therapy in patients with Noonan syndrome
por: Seo, Go Hun, et al.
Publicado: (2018) -
Growth in Children With Noonan Syndrome and Effects of Growth Hormone Treatment on Adult Height
por: Libraro, Annachiara, et al.
Publicado: (2021) -
Effectiveness of growth hormone therapy in children with Noonan syndrome
por: Seok, Eun mi, et al.
Publicado: (2020)